Latest Materials News

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

Close the Loop Limited reports steady revenue but a sharp 50% drop in EBITDA for the second half of FY25, driven by operational challenges in North America. A leadership change and strategic shifts aim to stabilise growth.

Melody Gold has exercised its option to process gold surface materials at Horseshoe Metals’ Horseshoe Lights project, initiating a three-year exclusive licence that promises early cash flow to accelerate copper development.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Aguia Resources is ramping up production at its high-grade Santa Barbara gold project in Colombia while advancing a low-capital phosphate operation in Brazil, setting the stage for robust cash flow generation.

Vulcan Energy has extended its conditional debt commitment letter to September 2025, aligning with its revised financing timeline for the Lionheart Project. This move supports ongoing bank discussions and the potential inclusion of significant government funding.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.

Talga Group has cleared the last regulatory hurdle for its Nunasvaara South graphite mine in Sweden, paving the way for production of battery anode materials critical to the green transition.

Alma Metals Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with ASX rules.

Noxopharm’s Sofra™ technology has received promising external validation from BioRay Pharmaceutical, confirming its targeted anti-inflammatory potential and broad applicability in autoimmune disease therapies.

Bastion Minerals has confirmed it is finalising a JORC Mineral Resource Estimate for its ICE Copper Gold Project, explaining recent sharp price and volume movements in its shares. The company plans to announce the estimate by June 10, 2025.

Invion Limited has addressed ASX queries over the timing and content of its cleansing notice, confirming encouraging early results from its Phase I/II non-melanoma skin cancer trial using Photosoft™ technology.